• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[克罗恩病患者的药物依从程度——一所大学诊所特殊门诊护理单元的研究]

[Extent of drug compliance in Crohn disease patients--study of a special ambulatory care unit of a university clinic].

作者信息

Karbach U, Degen I, Ewe K

出版信息

Z Gastroenterol. 1984 Oct;22(10):573-9.

PMID:6150583
Abstract

Compliance with therapeutic regimes is an important factor in treatment of chronic diseases often overlooked by therapists. In 123 out-patients with Crohn's disease the reliability in taking the prescribed therapy with salazosulfapyridine (SASP) was studied over an one year period in a special out-patient clinic. 81,3% of the patients took SASP regularly. Sex and age of patients, activity of disease and the intake of other drugs had no influence on the compliance. The patients were fully informed regarding the nature of the illness, the effect of the drug prescribed and the side-effects which may occur. We conclude that these factors; the periodical check up in a special ambulance and a close relation between patient and physician may improve compliance to therapy.

摘要

遵循治疗方案是治疗慢性病的一个重要因素,但往往被治疗师忽视。在一家特殊的门诊诊所,对123例克罗恩病门诊患者在一年时间里服用规定的柳氮磺胺吡啶(SASP)治疗的依从性进行了研究。81.3%的患者定期服用SASP。患者的性别、年龄、疾病活动度以及其他药物的服用情况对依从性均无影响。已向患者充分告知疾病的性质、所开药物的疗效以及可能出现的副作用。我们得出结论,这些因素,即在特殊门诊进行定期检查以及患者与医生之间的密切关系,可能会提高治疗的依从性。

相似文献

1
[Extent of drug compliance in Crohn disease patients--study of a special ambulatory care unit of a university clinic].[克罗恩病患者的药物依从程度——一所大学诊所特殊门诊护理单元的研究]
Z Gastroenterol. 1984 Oct;22(10):573-9.
2
A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
Gastroenterology. 1982 Sep;83(3):541-9.
3
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.柳氮磺胺吡啶和美沙拉嗪用于克罗恩病维持治疗的荟萃分析
Am J Gastroenterol. 1994 Dec;89(12):2116-24.
4
[Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].[血清中磺胺吡啶水平的测定——控制柳氮磺胺吡啶剂量相关治疗的一种可能性]
Dtsch Z Verdau Stoffwechselkr. 1984;44(6):282-8.
5
[Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].柳氮磺胺吡啶(水杨酸偶氮磺胺吡啶)治疗克罗恩病的临床疗效。一项对照双盲研究
Ugeskr Laeger. 1974 Aug 5;136(32):1798-802.
6
[Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
Z Gastroenterol Verh. 1981 Jun;19:38-40.
7
Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.类风湿关节炎、风湿性多肌痛和痛风患者的依从性。
J Rheumatol. 2003 Jan;30(1):44-54.
8
[Pericarditis in chronic inflammatory bowel disease: underlying disease or side effects of therapy? Clinical problem solving].
Schweiz Med Wochenschr. 1996 Dec 14;126(50):2184-90.
9
Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.静脉注射免疫球蛋白(IVIg)用于激素抵抗型克罗恩病患者的实验研究。
Z Gastroenterol. 2007 Jul;45(7):605-8. doi: 10.1055/s-2007-963098.
10
Healing of perineal Crohn's disease with metronidazole.甲硝唑治疗会阴克罗恩病的疗效观察
Gastroenterology. 1980 Aug;79(2):357-65.

引用本文的文献

1
Inflammatory bowel disease: patients' expectations in the 1990s.炎症性肠病:20世纪90年代患者的期望
J R Soc Med. 1991 Mar;84(3):131-2. doi: 10.1177/014107689108400305.